Showing results (71-80 of 660) with videos related to
Sort By:
Pageof 66
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Neoadjuvant therapy before surgical treatmentRob Glynne-Jones, Ian ChauCurrent Opinion in Pharmacology|January 7, 2023
Is there still a place for radiotherapy in gastric cancer?Irene Y Chong, Ian ChauBritish Journal of Cancer|March 25, 2023
Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trialsAvani Athauda, Matthew Nankivell, Rupert Langer, et al.The Lancet. Oncology|January 29, 2010
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trialYu Jo Chua, Yolanda Barbachano, David Cunningham, et al.Clinical Colorectal Cancer|November 15, 2016
Attitudes of Patients With Gastrointestinal Cancers Toward Research BiopsiesSing Yu Moorcraft, Ruwaida Begum, David Cunningham, et al.Current Problems in Cancer|March 5, 2019
Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature reviewVasiliki Michalarea, Elisa Fontana, Alvaro Ingles Garces, et al.Annals of Hematology|October 26, 2013
GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphomaEliza A Hawkes, Sarah Barton, David Cunningham, et al.Clinical Nuclear Medicine|March 6, 2015
The role of routine clinical pretreatment 18F-FDG PET/CT in predicting outcome of colorectal liver metastasisHenry H Tam, Gary J Cook, Ian Chau, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 7, 2015
Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001-2010Elisa Fontana, Elizabeth C Smyth, David Cunningham, et al.Pageof 66